BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37884412)

  • 1. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
    Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
    Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
    Wymore Brand M; Anderson TK; Kitikoon P; Brian Kimble J; Otis N; Gauger PC; Souza CK; Kaplan B; Mogler M; Strait E; Vincent Baker AL
    Vaccine; 2022 Sep; 40(38):5569-5578. PubMed ID: 35987871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model.
    Pliasas VC; Menne Z; Aida V; Yin JH; Naskou MC; Neasham PJ; North JF; Wilson D; Horzmann KA; Jacob J; Skountzou I; Kyriakis CS
    Front Immunol; 2022; 13():915364. PubMed ID: 35874791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
    Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
    J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.
    Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL
    Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model.
    Rosu ME; Kok A; Bestebroer TM; de Meulder D; Verveer EP; Pronk MR; Dekker LJM; Luider TM; Richard M; van den Brand JMA; Fouchier RAM; Herfst S
    J Virol; 2022 Mar; 96(6):e0195921. PubMed ID: 35107371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.
    Rajao DS; Sandbulte MR; Gauger PC; Kitikoon P; Platt R; Roth JA; Perez DR; Loving CL; Vincent AL
    Virology; 2016 Apr; 491():79-88. PubMed ID: 26874588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.
    Braucher DR; Henningson JN; Loving CL; Vincent AL; Kim E; Steitz J; Gambotto AA; Kehrli ME
    Clin Vaccine Immunol; 2012 Nov; 19(11):1722-9. PubMed ID: 22933397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
    Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Characterization of Influenza A Virus Endemic Circulation in Suckling and Nursery Pigs Originating from Vaccinated Farms in the Same Production System.
    Dias AS; Baker ALV; Baker RB; Zhang J; Zeller MA; Kitikoon P; Gauger PC
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.
    Pliasas VC; Neasham PJ; Naskou MC; Neto R; Strate PG; North JF; Pedroza S; Chastain SD; Padykula I; Tompkins SM; Kyriakis CS
    Front Immunol; 2023; 14():1253626. PubMed ID: 37928521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.
    Van Reeth K; Van Gucht S; Pensaert M
    Vet Rec; 2003 Jul; 153(1):9-13. PubMed ID: 12877210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.
    Van Reeth K; Gregory V; Hay A; Pensaert M
    Vaccine; 2003 Mar; 21(13-14):1375-81. PubMed ID: 12615433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.